Home » Topics » BioWorld Science

BioWorld Science
RSS

Toripalimab approved in China for locally advanced or metastatic urothelial carcinoma

April 13, 2021

BAY-2476568, a reversible, potent and selective EGFR inhibitor for lung cancer

April 13, 2021

New acid ceramidase inhibitors identified by BIAL Biotech, Istituto Italiano di Tecnologia

April 13, 2021

New antibiotic prodrugs synthesized at Brandeis University

April 13, 2021

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare present new GTPase KRAS inhibitors

April 13, 2021

Biosion presents nano-antibodies targeting B-cell maturation antigen

April 13, 2021

Nanjing Huawe Medicine Technology Development patents IAP inhibitors

April 13, 2021

Topline data presented from phase II KINETIC study of SAGE-324 in essential tremor

April 13, 2021

Phase III DARE-19 study of Farxiga in COVID-19 does not meet primary endpoints

April 13, 2021

New phase III study assesses contraceptive efficacy of relugolix combination tablet

April 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...